|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01548 GENSCRIPT BIO
Nominal 
10.880 0.000 (0.000%) | 2023/12 - Final USD(K$) | %Chg (Compare to Final) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | 2019/12 USD(K$) | |
| Turnover | 839,529 | 34.175% | 625,698 | 490,096 | 390,846 | 273,354 |
| Cost of Sales | (429,976) | 33.693% | (321,615) | (207,578) | (134,953) | (93,064) |
| Gross Profit | 409,553 | 34.685% | 304,083 | 282,518 | 255,893 | 180,290 |
| 2023/12 - Final USD(K$) | %Chg (Compare to Final) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | 2019/12 USD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 27,020 | 340.065% | 6,140 | (140,864) | (79,977) | (1,851) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (1,384) | 5025.926% | (27) | 0 | (599) | (308) | |
| Profit / (Loss) before Taxation | (350,979) | -18.697% | (431,690) | (517,363) | (281,900) | (113,690) | |
| Taxation | (4,142) | -- | 3,719 | (964) | 477 | (3,826) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 259,644 | 29.099% | 201,120 | 159,615 | 76,478 | 20,604 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (95,477) | -57.912% | (226,851) | (358,712) | (204,945) | (96,912) | |
| 2023/12 - Final USD(K$) | %Chg (Compare to Final) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | 2019/12 USD(K$) | |
| Net Finance Costs / (Income) | 27,510 | 107.325% | 13,269 | (407) | 1,134 | (7,569) |
| Depreciation & Amortisation | 74,046 | 15.250% | 64,248 | 47,779 | 32,895 | 20,642 |
| Directors' Emoluments | 2,294 | -24.589% | 3,042 | 2,860 | 1,865 | 1,783 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -4.530 | -58.133% | -10.820 | -17.670 | -10.780 | -5.230 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.136) | -- | (0.057) | (0.067) | (0.079) | (0.016) |
| NBV per share ($) | 0.655 | -- | 0.478 | 0.498 | 0.462 | 0.204 |
| Remarks: | Real time quote last updated: 11/11/2024 13:16 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | USD -175,115,000 |
| %Change | 87.127% |
| EPS / (LPS) | USD -0.083 |
| NBV Per Share ($) | USD 0.571 |